par Metzger-Filho, Otto;Vora, Tushar Shailesh 
;Awada, Ahmad
Référence Expert opinion on investigational drugs, 19 Suppl 1, page (S31-S39)
Publication Publié, 2010-04
;Awada, Ahmad Référence Expert opinion on investigational drugs, 19 Suppl 1, page (S31-S39)
Publication Publié, 2010-04
Article révisé par les pairs
| Titre: |
|
| Auteur: | Metzger-Filho, Otto; Vora, Tushar Shailesh; Awada, Ahmad |
| Informations sur la publication: | Expert opinion on investigational drugs, 19 Suppl 1, page (S31-S39) |
| Statut de publication: | Publié, 2010-04 |
| Sujet CREF: | Cancérologie |
| Mots-clés: | Adjuvant therapy |
| Chemotherapy | |
| Human epidermal growth factor receptor-2 (HER2) | |
| Metastatic breast cancer | |
| Trastuzumab | |
| Tyrosine kinase inhibitors | |
| MeSH keywords: | Antibodies, Monoclonal -- administration & dosage |
| Antibodies, Monoclonal, Humanized | |
| Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics -- therapeutic use | |
| Breast Neoplasms -- drug therapy -- pathology | |
| Chemotherapy, Adjuvant -- methods | |
| Disease Progression | |
| Drug Delivery Systems | |
| Drug Resistance, Neoplasm | |
| Female | |
| Humans | |
| Neoplasm Metastasis | |
| Receptor, erbB-2 -- antagonists & inhibitors -- metabolism | |
| Signal Transduction -- drug effects | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Review | |
| SCOPUS: cp.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1354-3784 |
| info:doi/10.1517/13543781003730135 | |
| info:scp/77950682786 | |
| info:pmid/20374028 |
